Status:
COMPLETED
The Usability, Feasibility, and Tolerability of Virtual Reality for Rehabilitation From COVID-19
Lead Sponsor:
Radboud University Medical Center
Conditions:
Coronavirus
Post Intensive Care Unit Syndrome
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
Patients who receive intensive care are known to be at high risk for physical, psychological, and cognitive impairments, a constellation known as PICS. COVID-19 patients are expected to have high chan...
Eligibility Criteria
Inclusion
- Patient has had COVID-19.
- Patient has an indication for physical therapy in the context of rehabilitation after COVID-19.
- At the day of recruitment, the estimated length of the physical therapy is at least 3 weeks after inclusion.
- Patient is willing and able to comply with the study protocol.
- Patient is at least 16 years old on the day the informed consent form will be signed.
- Patient can read and understand the Dutch language.
Exclusion
- The patient is participating in another study interfering with this study.
- Patient has difficulties to handle virtual reality:
- Patient suffers from delirium or acute confusional state.
- Patient has (a history of) dementia, seizure, or epilepsy.
- Patient has severe hearing/visual impairment not corrected.
- The skin of the patient's head or face is not intact (for example head wounds, psoriasis, eczema).
- Patient has a high risk of contamination with a therapy resistant micro-organism e.g. MRSA.
- Patients suffers from severe anxiety or depression (HADS≥16).
- Red flags (see Appendix 1).
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2021
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04505761
Start Date
August 1 2020
End Date
March 31 2021
Last Update
April 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboud university medical center
Nijmegen, Gelderland, Netherlands, 6525 GA